Topic - Schering-Plough Corp.

Subscribe to this topic via RSS or ATOM
Related Stories
  • Merck posts Q4 loss due to restructuring charges

    Drugmaker Merck & Co. said Thursday it lost $531 million in the fourth quarter due to nearly $4 billion charges, including writeoffs and restructuring costs from its acquisition of Schering-Plough Corp. in 2009.

  • Panel hearings over Merck's dispute with J&J end

    Drugmaker Merck & Co. said Thursday it doesn't expect arbitrators to rule until sometime next year on its multi-billion-dollar dispute with Johnson & Johnson over rights to two lucrative drugs for immune disorders.

  • Merck to appeal $4.6M verdict in Mass. fraud case

    Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said Thursday.

  • Merck, J&J arbitration on drug rights starts soon

    Drugmaker Merck & Co. said Tuesday that arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis and other immune disorders.

More Stories →

Happening Now